RTTNews | Oct 26, 2020 07:15AM EDT

07:15 Monday, October 26, 2020 (RTTNews) - BioXcel Therapeutics Gets FDA Clearance Of IND For Phase 2 Trial With BXCL501 For Agitation Associated With Delirium

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved